These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 21156726)

  • 1. Epigenetic suppression of the TGF-beta pathway revealed by transcriptome profiling in ovarian cancer.
    Matsumura N; Huang Z; Mori S; Baba T; Fujii S; Konishi I; Iversen ES; Berchuck A; Murphy SK
    Genome Res; 2011 Jan; 21(1):74-82. PubMed ID: 21156726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TGF-β induces global changes in DNA methylation during the epithelial-to-mesenchymal transition in ovarian cancer cells.
    Cardenas H; Vieth E; Lee J; Segar M; Liu Y; Nephew KP; Matei D
    Epigenetics; 2014 Nov; 9(11):1461-72. PubMed ID: 25470663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytidine monophosphate kinase is inhibited by the TGF-β signalling pathway through the upregulation of miR-130b-3p in human epithelial ovarian cancer.
    Zhou D; Zhang L; Sun W; Guan W; Lin Q; Ren W; Zhang J; Xu G
    Cell Signal; 2017 Jul; 35():197-207. PubMed ID: 28414100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. POSTN/TGFBI-associated stromal signature predicts poor prognosis in serous epithelial ovarian cancer.
    Karlan BY; Dering J; Walsh C; Orsulic S; Lester J; Anderson LA; Ginther CL; Fejzo M; Slamon D
    Gynecol Oncol; 2014 Feb; 132(2):334-42. PubMed ID: 24368280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA hypomethylation-mediated activation of Cancer/Testis Antigen 45 (CT45) genes is associated with disease progression and reduced survival in epithelial ovarian cancer.
    Zhang W; Barger CJ; Link PA; Mhawech-Fauceglia P; Miller A; Akers SN; Odunsi K; Karpf AR
    Epigenetics; 2015; 10(8):736-48. PubMed ID: 26098711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive methylome analysis of ovarian tumors reveals hedgehog signaling pathway regulators as prognostic DNA methylation biomarkers.
    Huang RL; Gu F; Kirma NB; Ruan J; Chen CL; Wang HC; Liao YP; Chang CC; Yu MH; Pilrose JM; Thompson IM; Huang HC; Huang TH; Lai HC; Nephew KP
    Epigenetics; 2013 Jun; 8(6):624-34. PubMed ID: 23774800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human epithelial-type ovarian tumour marker beta-2-microglobulin is regulated by the TGF-β signaling pathway.
    Sun W; Gui L; Zuo X; Zhang L; Zhou D; Duan X; Ren W; Xu G
    J Transl Med; 2016 Mar; 14():75. PubMed ID: 26983758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant TGFβ/SMAD4 signaling contributes to epigenetic silencing of a putative tumor suppressor, RunX1T1 in ovarian cancer.
    Yeh KT; Chen TH; Yang HW; Chou JL; Chen LY; Yeh CM; Chen YH; Lin RI; Su HY; Chen GC; Deatherage DE; Huang YW; Yan PS; Lin HJ; Nephew KP; Huang TH; Lai HC; Chan MW
    Epigenetics; 2011 Jun; 6(6):727-39. PubMed ID: 21540640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and epigenetic regulation of angiogenesis-related factors during dormancy and recurrent growth of ovarian carcinoma.
    Lyu T; Jia N; Wang J; Yan X; Yu Y; Lu Z; Bast RC; Hua K; Feng W
    Epigenetics; 2013 Dec; 8(12):1330-46. PubMed ID: 24135786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crk-like adapter protein is required for TGF-β-induced AKT and ERK-signaling pathway in epithelial ovarian carcinomas.
    Cheng S; Guo J; Yang Q; Han L
    Tumour Biol; 2015 Feb; 36(2):915-9. PubMed ID: 25307974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic silencing of DKK2 and Wnt signal pathway components in human ovarian carcinoma.
    Zhu J; Zhang S; Gu L; Di W
    Carcinogenesis; 2012 Dec; 33(12):2334-43. PubMed ID: 22964660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of the grainyhead transcription factor 2 gene (GRHL2) inhibits the proliferation, migration, invasion and mediates cell cycle arrest of ovarian cancer cells.
    Faddaoui A; Sheta R; Bachvarova M; Plante M; Gregoire J; Renaud MC; Sebastianelli A; Gobeil S; Morin C; Ghani K; Bachvarov D
    Cell Cycle; 2017 Apr; 16(7):693-706. PubMed ID: 28278050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concordant epigenetic silencing of transforming growth factor-beta signaling pathway genes occurs early in breast carcinogenesis.
    Hinshelwood RA; Huschtscha LI; Melki J; Stirzaker C; Abdipranoto A; Vissel B; Ravasi T; Wells CA; Hume DA; Reddel RR; Clark SJ
    Cancer Res; 2007 Dec; 67(24):11517-27. PubMed ID: 18089780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of dihydrotestosterone (DHT) on TGF-β1 signaling pathway in epithelial ovarian cancer cells.
    Kohan-Ivani K; Gabler F; Selman A; Vega M; Romero C
    J Cancer Res Clin Oncol; 2016 Jan; 142(1):47-58. PubMed ID: 26091707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene expression profile analysis in response to α1,2-fucosyl transferase (FUT1) gene transfection in epithelial ovarian carcinoma cells.
    Gao S; Zhu L; Feng H; Hu Z; Jin S; Song Z; Liu D; Liu J; Hao Y; Li X; Lin B
    Tumour Biol; 2016 Sep; 37(9):12251-12262. PubMed ID: 27240592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pyridoxine 5'-phosphate oxidase is a novel therapeutic target and regulated by the TGF-β signalling pathway in epithelial ovarian cancer.
    Zhang L; Zhou D; Guan W; Ren W; Sun W; Shi J; Lin Q; Zhang J; Qiao T; Ye Y; Wu Y; Zhang Y; Zuo X; Connor KL; Xu G
    Cell Death Dis; 2017 Dec; 8(12):3214. PubMed ID: 29238081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic analysis of sporadic and Lynch-associated ovarian cancers reveals histology-specific patterns of DNA methylation.
    Niskakoski A; Kaur S; Staff S; Renkonen-Sinisalo L; Lassus H; Järvinen HJ; Mecklin JP; Bützow R; Peltomäki P
    Epigenetics; 2014 Dec; 9(12):1577-87. PubMed ID: 25625843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic activation of MGAT3 and corresponding bisecting GlcNAc shortens the survival of cancer patients.
    Kohler RS; Anugraham M; López MN; Xiao C; Schoetzau A; Hettich T; Schlotterbeck G; Fedier A; Jacob F; Heinzelmann-Schwarz V
    Oncotarget; 2016 Aug; 7(32):51674-51686. PubMed ID: 27429195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Promoter hypermethylation contributes to frequent inactivation of a putative conditional tumor suppressor gene connective tissue growth factor in ovarian cancer.
    Kikuchi R; Tsuda H; Kanai Y; Kasamatsu T; Sengoku K; Hirohashi S; Inazawa J; Imoto I
    Cancer Res; 2007 Aug; 67(15):7095-105. PubMed ID: 17671176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression profiling identifies altered expression of genes that contribute to the inhibition of transforming growth factor-beta signaling in ovarian cancer.
    Sunde JS; Donninger H; Wu K; Johnson ME; Pestell RG; Rose GS; Mok SC; Brady J; Bonome T; Birrer MJ
    Cancer Res; 2006 Sep; 66(17):8404-12. PubMed ID: 16951150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.